These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Doctors are currently using stem cells to treat a variety of medical conditions — and that list could soon become even larger ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

Add Alzheimer's disease to the list of conditions that might benefit ... Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported Thursday in the journal ...

Eli Lilly' s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...